These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1297 related items for PubMed ID: 16490472

  • 21. Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level.
    Varas-Lorenzo C, Maguire A, Castellsague J, Perez-Gutthann S.
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):366-76. PubMed ID: 16897817
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and safety of celecoxib versus diclofenac and omeprazole in elderly arthritis patients: a subgroup analysis of the CONDOR trial.
    Kellner HL, Li C, Essex MN.
    Curr Med Res Opin; 2012 Sep; 28(9):1537-45. PubMed ID: 22852870
    [Abstract] [Full Text] [Related]

  • 23. Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease.
    Ray WA, Varas-Lorenzo C, Chung CP, Castellsague J, Murray KT, Stein CM, Daugherty JR, Arbogast PG, García-Rodríguez LA.
    Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):155-63. PubMed ID: 20031832
    [Abstract] [Full Text] [Related]

  • 24. Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs.
    Zhao SZ, Wentworth C, Burke TA, Makuch RW.
    Pharmacoepidemiol Drug Saf; 2004 May; 13(5):277-87. PubMed ID: 15133778
    [Abstract] [Full Text] [Related]

  • 25. Blood pressure destabilization and related healthcare utilization among hypertensive patients using nonspecific NSAIDs and COX-2-specific inhibitors.
    Zhao SZ, Burke TA, Whelton A, von Allmen H, Henderson SC.
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S401-13. PubMed ID: 12416790
    [Abstract] [Full Text] [Related]

  • 26. Rofecoxib in rheumatoid arthritis: new indication. No better that other NSAIDS.
    Prescrire Int; 2003 Jun; 12(65):89-90. PubMed ID: 12825570
    [Abstract] [Full Text] [Related]

  • 27. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial.
    Chan FK, Lanas A, Scheiman J, Berger MF, Nguyen H, Goldstein JL.
    Lancet; 2010 Jul 17; 376(9736):173-9. PubMed ID: 20638563
    [Abstract] [Full Text] [Related]

  • 28. Efficacy and tolerability of celecoxib compared with diclofenac slow release in the treatment of acute ankle sprain in an Asian population.
    Nadarajah A, Abrahan L, Lau FL, Hwang LJ, Fakir-Bolte C.
    Singapore Med J; 2006 Jun 17; 47(6):534-42. PubMed ID: 16752024
    [Abstract] [Full Text] [Related]

  • 29. Celecoxib in osteoarthritis and rheumatoid arthritis: new preparation. As disappointing as rofecoxib.
    Prescrire Int; 2001 Apr 17; 10(52):46-9. PubMed ID: 11718158
    [Abstract] [Full Text] [Related]

  • 30. Efficacy and safety of aceclofenac in the treatment of osteoarthritis: a randomized double-blind comparative clinical trial versus diclofenac - an Indian experience.
    Pareek A, Chandanwale AS, Oak J, Jain UK, Kapoor S.
    Curr Med Res Opin; 2006 May 17; 22(5):977-88. PubMed ID: 16709320
    [Abstract] [Full Text] [Related]

  • 31. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
    Goldstein JL, Aisenberg J, Lanza F, Schwartz H, Sands GH, Berger MF, Pan S.
    Clin Ther; 2006 Mar 17; 28(3):340-51. PubMed ID: 16750449
    [Abstract] [Full Text] [Related]

  • 32. Efficacy and safety of diclofenac-cholestyramine and celecoxib in osteoarthritis.
    Suárez-Otero R, Robles-San Román M, Jaimes-Hernández J, Oropeza-De La Madrid E, Medina-Peñaloza RM, Rosas-Ramos R, Castañeda-Hernández G.
    Proc West Pharmacol Soc; 2002 Mar 17; 45():26-8. PubMed ID: 12434517
    [No Abstract] [Full Text] [Related]

  • 33. A prospective study comparing celecoxib with naproxen in children with juvenile rheumatoid arthritis.
    Foeldvari I, Szer IS, Zemel LS, Lovell DJ, Giannini EH, Robbins JL, West CR, Steidle G, Krishnaswami S, Bloom BJ.
    J Rheumatol; 2009 Jan 17; 36(1):174-82. PubMed ID: 19012356
    [Abstract] [Full Text] [Related]

  • 34. A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: results from two randomized, parallel-group, placebo-controlled trials.
    Cryer BL, Sostek MB, Fort JG, Svensson O, Hwang C, Hochberg MC.
    Ann Med; 2011 Dec 17; 43(8):594-605. PubMed ID: 22017620
    [Abstract] [Full Text] [Related]

  • 35. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
    Hochberg MC.
    Semin Arthritis Rheum; 2002 Dec 17; 32(3 Suppl 1):4-14. PubMed ID: 12528069
    [Abstract] [Full Text] [Related]

  • 36. Celecoxib is efficacious and well tolerated in treating signs and symptoms of ankylosing spondylitis.
    Barkhuizen A, Steinfeld S, Robbins J, West C, Coombs J, Zwillich S.
    J Rheumatol; 2006 Sep 17; 33(9):1805-12. PubMed ID: 16960941
    [Abstract] [Full Text] [Related]

  • 37. The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor.
    Goldstein JL, Lowry SC, Lanza FL, Schwartz HI, Dodge WE.
    Aliment Pharmacol Ther; 2006 May 15; 23(10):1489-98. PubMed ID: 16669964
    [Abstract] [Full Text] [Related]

  • 38. Cost of heart failure among hypertensive users of nonspecific NSAIDs and COX-2-specific inhibitors.
    Zhao SZ, Burke TA, Whelton A, von Allmen H, Henderson SC.
    Am J Manag Care; 2002 Oct 15; 8(15 Suppl):S414-27. PubMed ID: 12416791
    [Abstract] [Full Text] [Related]

  • 39. Celecoxib versus a non-selective NSAID plus proton-pump inhibitor: what are the considerations?
    Chen JT, Pucino F, Resman-Targoff BH.
    J Pain Palliat Care Pharmacother; 2006 Oct 15; 20(4):11-32. PubMed ID: 17182503
    [Abstract] [Full Text] [Related]

  • 40. Incidence of outpatient physician claims for upper gastrointestinal symptoms among new users of celecoxib, ibuprofen, and naproxen in an insured population in the United States.
    Goldstein JL, Zhao SZ, Burke TA, Palmer R, von Allmen H, Henderson SC.
    Am J Gastroenterol; 2003 Dec 15; 98(12):2627-34. PubMed ID: 14687808
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 65.